| 3700 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
2396: Diminished differentiation of activated B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3699 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
2395: Diminished proliferation of activated B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3698 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
2394: Lower survival B lymphocytes |
Dec 3, 2025 |
Dec 3, 2025 |
1 AOP
|
| 3697 |
1507: Activation of PPARγ |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Dec 3, 2025 |
Dec 3, 2025 |
None
|
| 3696 |
2388: photoproducts generate ROS |
2363: Mito ROS dysfunction |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3695 |
2388: photoproducts generate ROS |
2389: Altered steroidogenesis |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3694 |
2390: reproductive hormonal Imbalance |
2391: Reduced fertility |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3693 |
1262: Apoptosis |
2391: Reduced fertility |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3692 |
2389: Altered steroidogenesis |
2390: reproductive hormonal Imbalance |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3691 |
2363: Mito ROS dysfunction |
1262: Apoptosis |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3690 |
1392: Increase, Oxidative Stress |
2363: Mito ROS dysfunction |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3689 |
2388: photoproducts generate ROS |
1392: Increase, Oxidative Stress |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3688 |
2387: Nuclear receptor binding / steroidogenic enzyme interference |
2389: Altered steroidogenesis |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3687 |
1994: Ferroptosis |
902: Inflammation, Liver |
Nov 4, 2025 |
Nov 4, 2025 |
1 AOP
|
| 3686 |
2386: Lipid-peroxidation overload |
1994: Ferroptosis |
Nov 4, 2025 |
Nov 4, 2025 |
None
|
| 3685 |
1417: NFE2/Nrf2 repression |
2386: Lipid-peroxidation overload |
Nov 4, 2025 |
Nov 4, 2025 |
None
|
| 3684 |
2385: Suppression of Keap1 cysteine oxidation |
1417: NFE2/Nrf2 repression |
Nov 4, 2025 |
Nov 4, 2025 |
1 AOP
|
| 3683 |
28: Reduction, Angiogenesis |
2383: Increase, Hemopericardium |
Oct 30, 2025 |
Oct 30, 2025 |
1 AOP
|
| 3682 |
948: reduced production, VEGF |
28: Reduction, Angiogenesis |
Oct 30, 2025 |
Oct 30, 2025 |
1 AOP
|
| 3681 |
227: Activation, PPARα |
948: reduced production, VEGF |
Oct 30, 2025 |
Oct 30, 2025 |
1 AOP
|
| 3680 |
1115: Increase, ROS |
2384: Decrease, Vascular integrity |
Oct 30, 2025 |
Oct 30, 2025 |
1 AOP
|
| 3679 |
2383: Increase, Hemopericardium |
947: Increase, Early Life Stage Mortality |
Oct 30, 2025 |
Oct 30, 2025 |
3 AOPs
|
| 3678 |
2384: Decrease, Vascular integrity |
2383: Increase, Hemopericardium |
Oct 30, 2025 |
Oct 30, 2025 |
2 AOPs
|
| 3677 |
1771: Decrease, ATP pool |
2384: Decrease, Vascular integrity |
Oct 30, 2025 |
Oct 30, 2025 |
1 AOP
|
| 3676 |
1312: Increase, Fatty acid β-oxidation |
1446: Decrease, Coupling of OXPHOS |
Oct 30, 2025 |
Oct 30, 2025 |
2 AOPs
|